Published in Stroke on December 08, 2011
Efficacy and safety assessment of acupuncture and nimodipine to treat mild cognitive impairment after cerebral infarction: a randomized controlled trial. BMC Complement Altern Med (2016) 1.08
Protection after stroke: cellular effectors of neurovascular unit integrity. Front Cell Neurosci (2014) 0.97
Impact of different operational definitions on mild cognitive impairment rate and MMSE and MoCA performance in transient ischaemic attack and stroke. Cerebrovasc Dis (2013) 0.95
Defining and validating a short form Montreal Cognitive Assessment (s-MoCA) for use in neurodegenerative disease. J Neurol Neurosurg Psychiatry (2016) 0.87
Validation of NINDS-CSN neuropsychological battery for vascular cognitive impairment in Chinese stroke patients. BMC Neurol (2015) 0.86
Predictive value of MoCA in the acute phase of stroke on the diagnosis of mid-term cognitive impairment. J Neurol (2013) 0.86
Routine cognitive screening in older patients admitted to acute medicine: abbreviated mental test score (AMTS) and subjective memory complaint versus Montreal Cognitive Assessment and IQCODE. Age Ageing (2015) 0.86
The Addenbrooke's Cognitive Examination Revised (ACE-R) and its sub-scores: normative values in an Italian population sample. Neurol Sci (2015) 0.85
Cognitive performance after stroke--the Framingham Heart Study. Int J Stroke (2014) 0.84
Concordance of the Montreal cognitive assessment with standard neuropsychological measures. Alzheimers Dement (Amst) (2015) 0.83
Methodological factors in determining rates of dementia in transient ischemic attack and stroke: (I) impact of baseline selection bias. Stroke (2015) 0.83
Cut-off scores of a brief neuropsychological battery (NBACE) for Spanish individual adults older than 44 years old. PLoS One (2013) 0.83
Cognitive impairment and memory dysfunction after a stroke diagnosis: a post-stroke memory assessment. Neuropsychiatr Dis Treat (2014) 0.82
Questionnaire assessment of usual practice in mood and cognitive assessment in Scottish stroke units. Disabil Rehabil (2013) 0.80
Methodological Factors in Determining Risk of Dementia After Transient Ischemic Attack and Stroke: (III) Applicability of Cognitive Tests. Stroke (2015) 0.80
Methodological Factors in Determining Risk of Dementia After Transient Ischemic Attack and Stroke: (II) Effect of Attrition on Follow-Up. Stroke (2015) 0.79
Kidney disease and cognitive function: African American-diabetes heart study MIND. Am J Nephrol (2014) 0.79
Quick screening of cognitive function in Indian multiple sclerosis patients using Montreal cognitive assessment test-short version. Ann Indian Acad Neurol (2013) 0.78
Subclinical Atherosclerosis Is Inversely Associated With Gray Matter Volume in African Americans With Type 2 Diabetes. Diabetes Care (2015) 0.78
Benefits of virtual reality based cognitive rehabilitation through simulated activities of daily living: a randomized controlled trial with stroke patients. J Neuroeng Rehabil (2016) 0.78
Cognitive assessments for the early diagnosis of dementia after stroke. Neuropsychiatr Dis Treat (2014) 0.77
Post-stroke memory impairment among patients with vascular mild cognitive impairment. BMC Neurol (2014) 0.77
Baseline characteristics, analysis plan and report on feasibility for the Prevention Of Decline in Cognition After Stroke Trial (PODCAST). Trials (2015) 0.76
Cerebral Blood Flow Alterations as Assessed by 3D ASL in Cognitive Impairment in Patients with Subcortical Vascular Cognitive Impairment: A Marker for Disease Severity. Front Aging Neurosci (2016) 0.76
PROspective MEmory Training to improve HEart failUre Self-care (PROMETHEUS): study protocol for a randomised controlled trial. Trials (2015) 0.76
Use of the MoCA in Detecting Early Alzheimer's Disease in a Spanish-Speaking Population with Varied Levels of Education. Dement Geriatr Cogn Dis Extra (2015) 0.76
Chemotherapy-related cognitive impairment in older patients with cancer. J Geriatr Oncol (2016) 0.76
Brain-derived neurotrophic factor (BDNF) Val66Met polymorphism and post-stroke dementia: a hospital-based study from northern Iran. Neurol Sci (2016) 0.76
Prevalence of mild cognitive impairment in employable patients after acute coronary event in cardiac rehabilitation. Vasc Health Risk Manag (2017) 0.75
Differences in cognitive profiles between traumatic brain injury and stroke: A comparison of the Montreal Cognitive Assessment and Mini-Mental State Examination. Chin J Traumatol (2016) 0.75
Cognitive status in patients hospitalized with acute decompensated heart failure. Am Heart J (2014) 0.75
Vascular contributions to cognitive impairment. Neurol Clin Pract (2015) 0.75
APOE Genotypes Associate With Cognitive Performance but Not Cerebral Structure: Diabetes Heart Study MIND. Diabetes Care (2016) 0.75
Cognitive and Functional Outcomes following Inpatient Rehabilitation in Patients with Acquired Brain Injury: A Prospective Follow-up Study. J Neurosci Rural Pract (2017) 0.75
Potential contribution of the neurodegenerative disorders risk loci to cognitive performance in an elderly male gout population. Medicine (Baltimore) (2017) 0.75
Therapeutic Strategies and Drug Development for Vascular Cognitive Impairment. J Am Heart Assoc (2017) 0.75
"Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res (1975) 301.74
The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc (2005) 27.90
Mild cognitive impairment--beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment. J Intern Med (2004) 16.58
The mini-mental state examination: a comprehensive review. J Am Geriatr Soc (1992) 15.32
Cerebral vascular accidents in patients over the age of 60. II. Prognosis. Scott Med J (1957) 8.43
Change in stroke incidence, mortality, case-fatality, severity, and risk factors in Oxfordshire, UK from 1981 to 2004 (Oxford Vascular Study). Lancet (2004) 7.33
National Institute of Neurological Disorders and Stroke-Canadian Stroke Network vascular cognitive impairment harmonization standards. Stroke (2006) 6.94
Population-based study of event-rate, incidence, case fatality, and mortality for all acute vascular events in all arterial territories (Oxford Vascular Study). Lancet (2005) 5.38
The Addenbrooke's Cognitive Examination Revised (ACE-R): a brief cognitive test battery for dementia screening. Int J Geriatr Psychiatry (2006) 4.73
Prevalence, incidence, and factors associated with pre-stroke and post-stroke dementia: a systematic review and meta-analysis. Lancet Neurol (2009) 4.60
The relation of the trail making test to organic brain damage. J Consult Psychol (1955) 4.33
The Set test as an aid to the detection of dementia in old people. Br J Psychiatry (1973) 3.52
Is the Montreal Cognitive Assessment superior to the Mini-Mental State Examination to detect poststroke cognitive impairment? A study with neuropsychological evaluation. Stroke (2011) 2.09
Variations in case definition affect prevalence but not outcomes of mild cognitive impairment. Neurology (2003) 1.82
Subclassifications for mild cognitive impairment: prevalence and predictive validity. Psychol Med (2003) 1.41
Early cognitive change in the general population: how do different definitions work? J Am Geriatr Soc (2007) 1.32
Predictors of stroke outcome using objective measurement scales. Stroke (1990) 1.27
Adult norms for the Rey-Osterrieth Complex Figure Test and for supplemental recognition and matching trials from the Extended Complex Figure Test. Clin Neuropsychol (1999) 1.18
Severity of CIND and MCI predict incidence of dementia in an ischemic stroke cohort. Neurology (2009) 1.09
Cerebrovascular disease and late-life depression. Am J Geriatr Psychiatry (2005) 1.06
The combined effect of age, education, and stroke on dementia and cognitive impairment no dementia in the elderly. Dement Geriatr Cogn Disord (2007) 1.05
The prognostic effects of poststroke cognitive impairment no dementia and domain-specific cognitive impairments in nondisabled ischemic stroke patients. Stroke (2011) 0.98
Validation and refinement of scores to predict very early stroke risk after transient ischaemic attack. Lancet (2007) 7.27
Effect of aspirin on long-term risk of colorectal cancer: consistent evidence from randomised and observational studies. Lancet (2007) 7.11
Effect of urgent treatment of transient ischaemic attack and minor stroke on early recurrent stroke (EXPRESS study): a prospective population-based sequential comparison. Lancet (2007) 6.29
Early decompressive surgery in malignant infarction of the middle cerebral artery: a pooled analysis of three randomised controlled trials. Lancet Neurol (2007) 6.15
Effect of daily aspirin on risk of cancer metastasis: a study of incident cancers during randomised controlled trials. Lancet (2012) 4.85
Prevalence, incidence, and factors associated with pre-stroke and post-stroke dementia: a systematic review and meta-analysis. Lancet Neurol (2009) 4.60
Effects of antihypertensive-drug class on interindividual variation in blood pressure and risk of stroke: a systematic review and meta-analysis. Lancet (2010) 4.06
Genetic risk factors for ischaemic stroke and its subtypes (the METASTROKE collaboration): a meta-analysis of genome-wide association studies. Lancet Neurol (2012) 3.93
Assessing and reporting heterogeneity in treatment effects in clinical trials: a proposal. Trials (2010) 3.45
Genome-wide association study identifies a variant in HDAC9 associated with large vessel ischemic stroke. Nat Genet (2012) 3.40
Effects of regular aspirin on long-term cancer incidence and metastasis: a systematic comparison of evidence from observational studies versus randomised trials. Lancet Oncol (2012) 3.37
Risk of stroke early after transient ischaemic attack: a systematic review and meta-analysis. Lancet Neurol (2007) 3.19
Carotid artery stenosis: accuracy of noninvasive tests--individual patient data meta-analysis. Radiology (2009) 2.94
Addition of brain and carotid imaging to the ABCD² score to identify patients at early risk of stroke after transient ischaemic attack: a multicentre observational study. Lancet Neurol (2010) 2.87
National Stroke Association guidelines for the management of transient ischemic attacks. Ann Neurol (2006) 2.82
Timing of birth and risk of multiple sclerosis: population based study. BMJ (2004) 2.56
The impact of preterm birth on hospital inpatient admissions and costs during the first 5 years of life. Pediatrics (2003) 2.46
Risk of myocardial infarction and vascular death after transient ischemic attack and ischemic stroke: a systematic review and meta-analysis. Stroke (2005) 2.38
Mitochondrial DNA haplogroups and risk of transient ischaemic attack and ischaemic stroke: a genetic association study. Lancet Neurol (2010) 2.33
Systematic review of methods and results of studies of the genetic epidemiology of ischemic stroke. Stroke (2003) 2.32
Terutroban versus aspirin in patients with cerebral ischaemic events (PERFORM): a randomised, double-blind, parallel-group trial. Lancet (2011) 2.16
Aspirin in the chemoprevention of colorectal neoplasia: an overview. Cancer Prev Res (Phila) (2011) 2.03
Systematic review and pooled analysis of published and unpublished validations of the ABCD and ABCD2 transient ischemic attack risk scores. Stroke (2010) 2.01
Underestimation of the early risk of recurrent stroke: evidence of the need for a standard definition. Stroke (2004) 2.01
Lead editorial: trials - using the opportunities of electronic publishing to improve the reporting of randomised trials. Trials (2006) 1.98
Treating individuals 3: from subgroups to individuals: general principles and the example of carotid endarterectomy. Lancet (2005) 1.96
Effect of urgent treatment for transient ischaemic attack and minor stroke on disability and hospital costs (EXPRESS study): a prospective population-based sequential comparison. Lancet Neurol (2009) 1.87
Meta-analysis in more than 17,900 cases of ischemic stroke reveals a novel association at 12q24.12. Neurology (2014) 1.85
Common variants at 6p21.1 are associated with large artery atherosclerotic stroke. Nat Genet (2012) 1.81
Critical cap thickness and rupture in symptomatic carotid plaques: the oxford plaque study. Stroke (2008) 1.80
Stroke Genetics Network (SiGN) study: design and rationale for a genome-wide association study of ischemic stroke subtypes. Stroke (2013) 1.80
Low risk of ipsilateral stroke in patients with asymptomatic carotid stenosis on best medical treatment: a prospective, population-based study. Stroke (2009) 1.75
Genetic heritability of ischemic stroke and the contribution of previously reported candidate gene and genomewide associations. Stroke (2012) 1.68
Transient isolated brainstem symptoms preceding posterior circulation stroke: a population-based study. Lancet Neurol (2012) 1.61
Medical academia is failing patients and clinicians. BMJ (2006) 1.59
Increased cerebral arterial pulsatility in patients with leukoaraiosis: arterial stiffness enhances transmission of aortic pulsatility. Stroke (2012) 1.57
Self-reported long-term needs after stroke. Stroke (2011) 1.53
Outcome after spontaneous and arteriovenous malformation-related intracerebral haemorrhage: population-based studies. Brain (2008) 1.53
Population-based study of incidence and outcome of acute aortic dissection and premorbid risk factor control: 10-year results from the Oxford Vascular Study. Circulation (2013) 1.53
Vessel wall contrast enhancement: a diagnostic sign of cerebral vasculitis. Cerebrovasc Dis (2008) 1.52
Shared genetic susceptibility to ischemic stroke and coronary artery disease: a genome-wide analysis of common variants. Stroke (2013) 1.51
Costs of stroke using patient-level data: a critical review of the literature. Stroke (2008) 1.50
Cost-effectiveness of diagnostic strategies prior to carotid endarterectomy. Ann Neurol (2005) 1.47
Feasibility, safety and cost of outpatient management of acute minor ischaemic stroke: a population-based study. J Neurol Neurosurg Psychiatry (2012) 1.45
Making the most of secondary prevention. Stroke (2007) 1.42
Reporting of consistency of blood pressure control in randomized controlled trials of antihypertensive drugs: a systematic review of 1372 trial reports. J Hypertens (2012) 1.40
Carotid artery imaging for secondary stroke prevention: both imaging modality and rapid access to imaging are important. Stroke (2009) 1.40
Antithrombotic drug use, cerebral microbleeds, and intracerebral hemorrhage: a systematic review of published and unpublished studies. Stroke (2010) 1.39
ABCD2 score predicts severity rather than risk of early recurrent events after transient ischemic attack. Stroke (2010) 1.37
Addition of brain infarction to the ABCD2 Score (ABCD2I): a collaborative analysis of unpublished data on 4574 patients. Stroke (2010) 1.35
Waiting times for carotid endarterectomy in UK: observational study. BMJ (2009) 1.34
Effects of visit-to-visit variability in systolic blood pressure on macrovascular and microvascular complications in patients with type 2 diabetes mellitus: the ADVANCE trial. Circulation (2013) 1.32
Identification, prognosis, and management of patients with carotid artery near occlusion. AJNR Am J Neuroradiol (2005) 1.30
Local versus general anaesthesia for carotid endarterectomy. Cochrane Database Syst Rev (2008) 1.26
Diffusion-weighted MRI in 300 patients presenting late with subacute transient ischemic attack or minor stroke. Stroke (2004) 1.25
Prognosis of vertebrobasilar transient ischaemic attack and minor stroke. Brain (2003) 1.24
Patient behavior immediately after transient ischemic attack according to clinical characteristics, perception of the event, and predicted risk of stroke. Stroke (2006) 1.23
Systematic review of the operative risks of carotid endarterectomy for recently symptomatic stenosis in relation to the timing of surgery. Stroke (2009) 1.22
Sex differences in heritability of ischemic stroke: a systematic review and meta-analysis. Stroke (2007) 1.22
Population-based study of determinants of initial secondary care costs of acute stroke in the United Kingdom. Stroke (2006) 1.20
A population-based study of the prevalence of fatigue after transient ischemic attack and minor stroke. Stroke (2009) 1.17
A population-based study of hospital care costs during 5 years after transient ischemic attack and stroke. Stroke (2012) 1.15
Population-based study of behavior immediately after transient ischemic attack and minor stroke in 1000 consecutive patients: lessons for public education. Stroke (2010) 1.14
Apolipoprotein(a) genetic sequence variants associated with systemic atherosclerosis and coronary atherosclerotic burden but not with venous thromboembolism. J Am Coll Cardiol (2012) 1.14
Mortality rates for stroke in England from 1979 to 2004: trends, diagnostic precision, and artifacts. Stroke (2008) 1.14
Lifestyle risk factors for ischemic stroke and transient ischemic attack in young adults in the Stroke in Young Fabry Patients study. Stroke (2012) 1.14
Risk of persistent cranial nerve injury after carotid endarterectomy. J Neurosurg (2004) 1.12
Potential confounding by intermediate phenotypes in studies of the genetics of ischaemic stroke. Cerebrovasc Dis (2004) 1.11
Site of carotid plaque ulceration in relation to direction of blood flow: an angiographic and pathological study. Cerebrovasc Dis (2003) 1.11
Quality of life after TIA and stroke: ten-year results of the Oxford Vascular Study. Neurology (2013) 1.08
Global stroke statistics. Int J Stroke (2014) 1.08
Population-based study of disability and institutionalization after transient ischemic attack and stroke: 10-year results of the Oxford Vascular Study. Stroke (2013) 1.07
GALA: an international multicentre randomised trial comparing general anaesthesia versus local anaesthesia for carotid surgery. Trials (2008) 1.06
Stroke: working toward a prioritized world agenda. Stroke (2010) 1.05
Patch angioplasty versus primary closure for carotid endarterectomy. Cochrane Database Syst Rev (2009) 1.05
17q25 Locus is associated with white matter hyperintensity volume in ischemic stroke, but not with lacunar stroke status. Stroke (2013) 1.04
Transient cognitive impairment in TIA and minor stroke. Stroke (2011) 1.04
Reporting of observational studies. BMJ (2007) 1.04
Mapping the modified Rankin scale (mRS) measurement into the generic EuroQol (EQ-5D) health outcome. Med Decis Making (2009) 1.04
Heritability of ischaemic stroke in women compared with men: a genetic epidemiological study. Lancet Neurol (2007) 1.03
Substantial underestimation of the need for outpatient services for TIA and minor stroke. Age Ageing (2007) 1.03